Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuliang Wu
Institutions:
Suzhou Municipal Hospital,
Nanjing Medical University
Observed institutions:
Suzhou Municipal Hospital,
Nanjing Medical University
ORCID:
0000-0001-5212-5700
Observed ORCID:
0000-0001-5212-5700
OpenAlex ID:
A5137039445
Supplementary Data 1 from PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti–PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial
2026
·
Jing Guo
, Yuliang Wu
, et al.
Data from PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti–PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial
2026
·
Jing Guo
, Yuliang Wu
, et al.
PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti–PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial
2026
·
Jing Guo
, Yuliang Wu
, et al.
·
Clinical Cancer Research
PDF
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type